Showing results (641-650 of 3,789) with videos related to
Sort By:
Pageof 379
Oncoimmunology|November 18, 2016
The ratio of CD8+/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situMichaela Semeraro, Julien Adam, Gautier Stoll, et al.Oncoimmunology|November 18, 2016
Melanomas prevent endothelial cell death under restrictive culture conditions by signaling through AKT and p38 MAPK/ ERK-1/2 cascadesAsha M Das, Mario Pescatori, Cindy E Vermeulen, et al.Oncoimmunology|November 18, 2016
Mini-intronic plasmid vaccination elicits tolerant LAG3+ CD8+ T cells and inferior antitumor responsesViswa Teja Colluru, Christopher D Zahm, Douglas G McNeelOncoimmunology|November 18, 2016
GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunityMichael S Magee, Crystal L Kraft, Tara S Abraham, et al.Oncoimmunology|November 18, 2016
Dense breast tissue in postmenopausal women is associated with a pro-inflammatory microenvironment in vivoAnnelie Abrahamsson, Anna Rzepecka, Thobias Romu, et al.Oncoimmunology|December 22, 2016
Responses to immune checkpoint inhibitors in nonagenariansRomany A N Johnpulle, Robert M Conry, Jeffrey A Sosman, et al.Oncoimmunology|December 22, 2016
Functional impairment of infiltrating T cells in human colorectal cancerEdward S Taylor, John L McCall, Adam Girardin, et al.Oncoimmunology|December 22, 2016
Neuroblastoma patients with high-affinity FCGR2A, -3A and stimulatory KIR 2DS2 treated by long-term infusion of anti-GD2 antibody ch14.18/CHO show higher ADCC levels and improved event-free survivalNikolai Siebert, Christian Jensen, Sascha Troschke-Meurer, et al.Oncoimmunology|December 22, 2016
Efficacy of glypican-3-derived peptide vaccine therapy on the survival of patients with refractory ovarian clear cell carcinomaShiro Suzuki, Jun Sakata, Fumi Utsumi, et al.Oncoimmunology|March 28, 2017
HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevanceBarbara Seliger, Matthias Kloor, Soldano FerronePageof 379